全文获取类型
收费全文 | 474篇 |
免费 | 33篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 14篇 |
妇产科学 | 18篇 |
基础医学 | 55篇 |
口腔科学 | 11篇 |
临床医学 | 46篇 |
内科学 | 103篇 |
皮肤病学 | 16篇 |
神经病学 | 27篇 |
特种医学 | 14篇 |
外科学 | 57篇 |
综合类 | 8篇 |
预防医学 | 58篇 |
眼科学 | 4篇 |
药学 | 51篇 |
中国医学 | 3篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 12篇 |
2022年 | 17篇 |
2021年 | 35篇 |
2020年 | 15篇 |
2019年 | 31篇 |
2018年 | 22篇 |
2017年 | 22篇 |
2016年 | 28篇 |
2015年 | 24篇 |
2014年 | 26篇 |
2013年 | 32篇 |
2012年 | 44篇 |
2011年 | 34篇 |
2010年 | 27篇 |
2009年 | 12篇 |
2008年 | 28篇 |
2007年 | 30篇 |
2006年 | 21篇 |
2005年 | 18篇 |
2004年 | 16篇 |
2003年 | 11篇 |
2002年 | 2篇 |
1997年 | 2篇 |
排序方式: 共有509条查询结果,搜索用时 0 毫秒
1.
2.
Mario Arpinati Gabriella Chirumbolo Benedetta Urbini Francesca Bonifazi Giuseppe Bandini Yogen Saunthararajah Alessandra Zagnoli Marta Stanzani Sadia Falcioni Giulia Perrone Sante Tura Michele Baccarani Damiano Rondelli 《Biology of blood and marrow transplantation》2004,10(2):106-115
Human dendritic cells (DC) comprise 2 subsets-plasmacytoid CD123(+) and myeloid CD11c(+) DC-that may have distinct roles in the regulation of immunity after allogeneic hematopoietic stem cell transplantation. In this study, we analyzed the kinetics of CD123(+) DC and CD11c(+) DC reconstitution in 31 patients who underwent transplantation with allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood (PB) stem cells from HLA-identical sibling donors after myeloablative conditioning. Lineage marker-negative HLA-DR(+) CD11c(+) CD11c(+) DC and lineage marker-negative HLA-DR(+) CD123(+) CD123(+) DC, as well as monocytes and lymphoid subsets, were enumerated in donor grafts and in the PB of patients at various time points after transplantation. Reconstitution of both CD11c(+) DC and CD123(+) DC to normal levels occurred within 6 to 12 months and was not affected by the diagnosis, preparatory regimen, or graft composition. However, PB CD11c(+) DC and CD123(+) DC counts were significantly reduced in patients with acute GVHD grade II to IV (at 1 and 3 months) and grade I (at 1 month). Patients with chronic GVHD instead showed reduced CD123(+) DC counts only 6 months after transplantation. Moreover, treatment with steroids (>0.1 mg/kg) was significantly associated with reduced PB CD11c(+) DC and CD123(+) DC counts at all time points after transplantation. In multivariate analysis, only acute GVHD affected DC reconstitution early after transplantation. These results will prompt new studies addressing whether DC reconstitution correlates with immunity against infectious agents or with graft-versus-tumor reactions after PB stem cell allotransplantation. 相似文献
3.
4.
Seema Irfan Mohammad Zeeshan Salima Rattani Joveria Farooqi Sadia Shakoor Rumina Hasan Afia Zafar 《Emerging infectious diseases》2021,27(3):936
We evaluated Salmonella enterica serotype Typhi strains isolated from all body sites in Pakistan during 2013–2018. Despite an increase in overall number of localized, extensively drug-resistant Salmonella Typhi in organ infections during 2018, there was no increase in the proportion of such isolates in comparison with non–extensively drug-resistant isolates. 相似文献
5.
6.
Sabri Tekin Hatice Özdoğan Mustafa Kemal Demir Hagar Soultan Sadia Zafar 《Transplantation proceedings》2021,53(4):1207-1210
Immunocompromised populations are at great risk of the current 2020 global emergency of coronavirus disease 2019 (COVID-19), and treatment of kidney transplant recipients with COVID-19 is currently not declared. Hence, the purpose of the study is to set a clear treatment regimen. We report here a therapeutic course of 2 patients who underwent transplant surgery in March 2020 and got infected soon after. Since the transplant, these 2 patients have received triple maintenance immunosuppressive therapy with oral tacrolimus, mycophenolate mofetil (MMF), and prednisone, and they have been regularly followed up at our hospital. The tacrolimus trough level was between 10 and 12 ng/mL. After the diagnosis of COVID-19, MMF was stopped and the tacrolimus dose was reduced so that blood level was between 4 and 6 ng/mL. The first patient was a 30-year-old man who, despite being treated with hydroxychloroquine, favipiravir, oseltamivir, and azithromycin therapy, died because of the presence of other comorbidities. The second case was a 58-year-old man who fully recovered from COVID-19 pneumonia with treatment with methylprednisolone, MMF, azithromycin, favipiravir, hydroxychloroquine, and reduction in immunosuppression dosage. This reflects the importance of using glucocorticoids in the treatment of COVID-19 along with other medications and the decreased mortality rate associated with their use. 相似文献
7.
8.
9.